One of the predefined secondary endpoints of the study was hospitalization for a primary diagnosis of congestive HF, which occurred in 2.4% of the 80-mg dose...
For the last decade, the primary clinical focus for reducing ischemic cardiovascular disease risk has centered on reducing low- density lipoprotein cholesterol...
Percutaneous coronary intervention (PCI) plus stenting and optimal medical therapy is no better at preventing future events than optimal medical therapy alone...
Clinical Text In 2004, more than 1 million coronary stent procedures were performed in the United States, about 85% of which were done electively in patients...
A diagnosis of obstructive sleep apnea (OSA) isn't needed for sleep disturbances to have an adverse effect on markers of cardiovascular risk, suggests a...
New recommendations for using coronary calcium scoring issued late last year concede that the imaging test may yield additional risk- stratification...
The advanced glycation end product inhibitor LR-90 has anti- inflammatory properties that may protect against diabetic vascular complications, according to a...
Two-year follow-up from the ENDEAVOR III trial suggests that the Endeavor zotarolimus-eluting stent may be equivalent to the sirolimus-eluting Cypher stent, in...
In patients with psoriatic arthritis, the human recombinant tumor necrosis factor (TNF)-binding protein onercept (Merck Serono, Geneva, Switzerland), decreases...
The presence of obstructive sleep apnea (OSA) in patients with heart failure significantly raises their risk of death, independent of ventricular function and...
A diagnosis of obstructive sleep apnea (OSA) isn't needed for sleep disturbances to have an adverse effect on markers of cardiovascular risk, suggests a...
For type-2 diabetic patients with inadequate blood glucose control despite treatment with two oral diabetes drugs, the addition of either insulin glargine or...
The pregnancy outcomes for women with type 1 diabetes remain poor with increased risk of major congenital malformation, stillbirth, premature delivery and...
EARDIP was established in 1999 by a steering committee of diabetes nurse specialists, midwives, physicians, obstetricians, paediatricians and CEMACH...
Most studies have lacked power to determine which factors contribute to the poor outcomes in women with type 2 diabetes, although poor preparation for...
Two prominent U.S. heart experts said studies of Merck & Co. Inc. arthritis drug Arcoxia (etoricoxib) revealed risks that should prevent its approval in the...
A nationwide survey of adults over the age of 40 has found that only 41% say they regularly take aspirin. Authors of a study examining the survey results say...
The US Food and Drug Administration (FDA) has granted 510(k) clearance for a wireless pressure management system in thoracic aortic aneurysm repair as well as...
Ten-year results from the Bypass Angioplasty Revascularization Investigation (BARI) trial show no significant long-term advantage of an initial strategy of...
Requiring patients to partially pay for their statin medications has negative effects on adherence to the lipid-lowering therapy, a new study has shown [1]....
Different ethnic groups develop clinically significant increases in lipid, glucose, or blood-pressure levels at much lower body-mass indexes (BMIs) than those...
Can patients undergoing PCI be discharged the same day of their procedure? Results from a European randomized trial appear to suggest this is possible, with...
Treatment with anakinra, a recombinant human interleukin-1-receptor antagonist, safely improves glycemia and beta-cell secretory function in patients with type...
Breastfeeding does not seem to protect against weight gain and the development of type 2 diabetes risk factors, according to a study conducted in a group of...
Twitching, flexing leg movements during sleep in people with restless leg syndrome (RLS) produce blood-pressure fluctuations that could contribute to the risk...
Researchers at Duke University have identified a new gene that appears to put individuals at greater risk of developing cardiovascular disease. The gene, known...
Vildagliptin, a new dipeptidyl peptidase-4 inhibitor, is a useful therapeutic option in patients with type 2 diabetes inadequately controlled with metformin...
Different ethnic groups develop clinically significant increases in lipid, glucose, or blood-pressure levels at much lower body-mass indexes (BMIs) than those...
Having problems with message search?
Fill out this form to ensure your group is one of the first to be migrated to the new message search system.
